1. Home
  2. KNSA vs IPAR Comparison

KNSA vs IPAR Comparison

Compare KNSA & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • IPAR
  • Stock Information
  • Founded
  • KNSA 2015
  • IPAR 1982
  • Country
  • KNSA United Kingdom
  • IPAR United States
  • Employees
  • KNSA N/A
  • IPAR N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • IPAR Package Goods/Cosmetics
  • Sector
  • KNSA Health Care
  • IPAR Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • IPAR Nasdaq
  • Market Cap
  • KNSA 2.6B
  • IPAR 3.1B
  • IPO Year
  • KNSA 2018
  • IPAR 1988
  • Fundamental
  • Price
  • KNSA $38.36
  • IPAR $87.38
  • Analyst Decision
  • KNSA Strong Buy
  • IPAR Strong Buy
  • Analyst Count
  • KNSA 7
  • IPAR 5
  • Target Price
  • KNSA $49.71
  • IPAR $145.60
  • AVG Volume (30 Days)
  • KNSA 546.2K
  • IPAR 241.4K
  • Earning Date
  • KNSA 10-28-2025
  • IPAR 11-05-2025
  • Dividend Yield
  • KNSA N/A
  • IPAR 3.66%
  • EPS Growth
  • KNSA N/A
  • IPAR 9.68
  • EPS
  • KNSA 0.47
  • IPAR 5.13
  • Revenue
  • KNSA $597,973,000.00
  • IPAR $1,463,838,000.00
  • Revenue This Year
  • KNSA $62.63
  • IPAR $4.04
  • Revenue Next Year
  • KNSA $29.93
  • IPAR $5.16
  • P/E Ratio
  • KNSA $82.19
  • IPAR $17.05
  • Revenue Growth
  • KNSA 55.68
  • IPAR 3.12
  • 52 Week Low
  • KNSA $17.82
  • IPAR $86.50
  • 52 Week High
  • KNSA $42.05
  • IPAR $148.15
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 52.71
  • IPAR 29.75
  • Support Level
  • KNSA $36.56
  • IPAR $87.64
  • Resistance Level
  • KNSA $39.66
  • IPAR $92.20
  • Average True Range (ATR)
  • KNSA 1.58
  • IPAR 2.86
  • MACD
  • KNSA -0.13
  • IPAR -0.36
  • Stochastic Oscillator
  • KNSA 50.78
  • IPAR 6.83

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: